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Abstract
Objectives
The objectives of this study were to determine incidence and risk factors of glucose intoler-
ance one year after delivery in a sub-cohort of Riyadh Mother and Baby Cohort Study
(RAHMA) study.
Methods
This is a follow-up study of a sub-cohort from RAHMA study from King Khalid University
Hospital (KKUH). All women from RAHMA database who completed one year since delivery
at KKUH were contacted by phone to participate in the study. Previously collected data from
RAHMA registry for each participant were linked to this study data. Clinical data measured
for each participant included current weight and height to calculate the BMI and waist cir-
cumference. Blood tests done for each participant were fasting blood glucose (FPG) and
HbA1c. Based on the blood tests results, participants were classified into three groups; dia-
betic, pre-diabetic and normal. The incidence of diabetes and prediabetes was calculated
for the whole cohort. Clinical, biochemical, and sociodemographic predictors of glucose
intolerance were compared between the three groups. Risk factors with P-value less than
0.05 were tested in multivariate regression model with bootstrapping to calculate the relative
risk (RR) and its 95% Bias corrected Confidence Interval (C.I.)
Results
From the sub-cohort, 407 women fulfilled the inclusion criteria and agreed to participate in
the study. From the study participants; 250 (61.4%) women were normoglycemic, 142
(35%) women had prediabetes and 15 (3.6%) women were diabetic. Following multivariable
regression analysis only history of gestational diabetes mellitus (GDM), (RR 1.74, 95% CI
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(1.06 to 2.84), P = 0.01), obesity (RR 1.69, 95% CI (1.01–3.11), P = 0.04) and diastolic
blood pressure, (RR 1.04, 95% CI (1.01–1.09), P = 0.03) remained as predictors of postpar-
tum glucose intolerance.
Conclusion
The incidence of postpartum glucose intolerance (diabetes and prediabetes) is very high in
Saudi women. Both GDM and obesity are strong predictors of glucose intolerance.
Introduction
Diabetes is becoming a global health problem and is one of the main causes of premature mor-
bidity and mortality [1].
Saudi Arabia is one of the top countries with the highest prevalence of diabetes [2]. More
than 25% of Saudi adults are diabetic, with 40% of those are unaware of their condition [3]. In
addition, 25% of the adult population are pre-diabetic [3]
The physiological changes of pregnancy create a state of carbohydrate intolerance mediated
by the pregnancy specific hormones, which increase the peripheral resistance to insulin and
call for more production of the hormone to maintain normal blood glucose levels during preg-
nancy [4].
One of the commonest glucose metabolism disorders of pregnancy is gestational diabetes
(GDM), which is defined as diabetes diagnosed during pregnancy that is clearly not pre-gesta-
tional in nature [5].
It is proven that women with history of GDM are at increased risk of developing type 2 dia-
betes mellitus, metabolic syndrome and cardiovascular diseases later in life [6,7].
Most of the women with GDM revert to normal glycemic tolerance following delivery,
however, they have seven-fold increased risk of developing type 2 diabetes compared to
women who did not have GDM [8]. The reported rate of progression to type 2 diabetes varied
considerably in different studies and is dependent on the period of follow up, the diagnostic
criteria for GDM and ethnicity of the studied population [9]. Other factors such as family his-
tory of type 2 diabetes, severity of hyperglycemia during pregnancy, need of insulin treatment,
and the anthropometric profile of the woman, are predicters of progression to type 2 diabetes
in women with history of GDM [10–13]
Evidence suggests that lifestyle modification and pharmacological interventions can pre-
vent or delay progression to type 2 diabetes in at risk population including women with history
of GDM [14–16]. Hence, the identification of at risk women with history of GDM through
postpartum screening programs, followed by appropriate interventions is expected to reduce
the burden of type 2 diabetes, considering that one in four Saudi women develops GDM dur-
ing pregnancy and is among the high-risk population for developing type 2 diabetes [17].
As per guidance of American diabetes association (ADA), different tests are equally effec-
tive for screening for prediabetes and diabetes including 75 oral glucose tolerance test
(OGTT), fasting plasma glucose (FPG) or glycosylated haemoglobin A1C (HbA1c) [18].
There is paucity of studies on progression to type 2 diabetes among postpartum Saudi
women. The objectives of this study were to determine incidence and risk factors of glucose
intolerance one year after delivery in a sub-cohort of Riyadh Mother and Baby Cohort Study
(RAHMA) study.
RAHMA; incidence of postpartum glucose intolerance
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Materials and methods
RAHMA is the first large multicentre, longitudinal cohort study which investigates pregnancy
outcomes in Saudi Arabia. The main objectives of the study were to examine the influence of
non-communicable diseases such as diabetes, hypertension, and obesity, on the mother and
the baby. The participating hospitals were selected randomly after stratification based on the
type of hospital (ministry of health, military, or teaching) and the number of beds which
ensured that the participants in the study were representatives of all the spectra of pregnant
women in Riyadh. The detailed methodology of the study has been previously reported [19].
In brief, participants completed a self-administered questionnaire providing information on
family socioeconomic and lifestyle status and antenatal history. In addition, maternal and neo-
natal outcomes were reported. A link was established between maternal laboratory data and
the study records [19].
This follow up study was conducted in a sub-cohort of participants of RAHMA from king
Khalid University Hospital (KKUH), which is a tertiary referral hospital with 800 beds. It has
all the essential departments including 20 operating theatres, an assisted reproduction unit
and a cardiac centre. The hospital provides free medical care to Saudi nationals and the staff of
King Saud University. The obstetrics department provides care for 3000–4000 deliveries per
year [19]. The hospital does not provide routine postnatal screening for hyperglycemia for
women with GDM.
Definitions
• GDM was diagnosed based on one or more abnormal value of the 75g oral glucose tolerance
test (OGTT) done between 24 and 34 gestation weeks using the following World Health
Organization (WHO) cut-off values [20]:
Fasting plasma glucose (FPG) 5.1–6.9 mmol/l (92–125 mg/dl).
1-Hour plasma glucose� 10.0 mmol/l (180 mg/dl).
2-Hour plasma glucose 8.5–11.0 mmol/l (153–199 mg/dl).
• Diabetes and prediabetes were diagnosed using either fasting plasma glucose (if the partici-
pant came fasting) or glycosylated haemoglobin A1C (HbA1c) levels according to the follow-
ing cut-off levels of the ADA [18]:
Fasting Plasma Glucose (FPG) values:
Normal < 5.6 mmol/l (100 mg/dl)
Prediabetes 5.6–6.9mmol/l (100 mg/dl to 125 mg/dl)
Diabetes� 7.0 mmol/l (126 mg/dl)
HbA1c values:
Normal < than 5.7% (39 mmol/mol)
Prediabetes 5.7% to 6.4% (39 to 46 mmol/mol)
Diabetes� 6.5% (48 mmol/mol)
• Maternal pre-pregnancy body mass index (BMI) was calculated from maternal recall of
weight prior to pregnancy and height measured during the first antenatal clinic. Current
BMI was calculated using the current maternal weight and height. Participants were
RAHMA; incidence of postpartum glucose intolerance
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classified according to the WHO BMI definitions as follows: underweight (<18.5 kg/m2),
normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2) and obese (� 30 kg/m2)
[21].
• A tape measure was used by one trained researcher to measure, waist circumference (WC) at
the mid-point, half-way between the right iliac crest and the lower costal region [22].
Study population
This is a follow-up study of subgroup of 3130 women from KKUH. All women who partici-
pated in RAHMA study from KKUH and met the inclusion criteria, were contacted one year
after each woman’s delivery date to participate in the study. The inclusion criteria for this sub-
cohort were the following:
1. Gestational age of 37–41 weeks at the time of delivery, calculated from the last menstrual
period and/or early ultrasound scan, when there is a difference between menstrual date and
ultrasound date the latter was taken as the correct date.
2. Singleton pregnancy
We excluded women with unknown glycaemic status, those with pre-GDM diagnosed
before or during pregnancy, women who were pregnant at the time of this study and those
who declined to participate in the study.
Interventions
All women from RAHMA database who delivered one year before at KKUH and fulfilled the
inclusion criteria, were contacted by phone to participate in this study. Women who agreed to
participate were invited to attend RAHMA outpatient clinic (research clinic) fasting for at
least eight hours before their appointment. The objectives of the study were explained again
face-to-face to each participant who subsequently signed an informed consent form. Previ-
ously collected data from RAHMA registry for each participant were linked to this study data;
including demographic profile, obstetric history such as parity, pre-pregnancy weight and type
of treatment of GDM in the index pregnancy (diet or insulin). Clinical data measured in each
participant included current weight and height to calculate the BMI in addition to waist cir-
cumference WC and systolic and diastolic blood pressure. Blood tests done for each partici-
pant were FPG and HbA1c levels.
Outcomes measures
Based on the results of blood tests participants were classified into three groups; diabetic, pre-
diabetic and normal. The incidence of diabetes and prediabetes was calculated in the whole
cohort and the relative risk (RR) of the known risk factors was calculated.
Statistical analysis
Statistical analysis was performed using SPSS version 21.0 (SPSS Inc., Chicago, IL, USA) for
Windows. Descriptive statistics in terms of average ± Standard deviation for quantitative vari-
ables and frequency and percentage for qualitative variables were used. Clinical, biochemical,
and sociodemographic characteristics of women who progressed to postpartum glucose intol-
erance were compared with women with normal glucose tolerance using Bivariate analysis.
One-way Analysis of Variance (ANOVA) was used to compare quantitative variables among
the three groups; normal glucose tolerance, impaired glucose tolerance and diabetics, and
RAHMA; incidence of postpartum glucose intolerance
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bootstrapping was conducted to improve precision of estimates. Chi-Square test was used to
evaluate the association between categorical variables and Fisher’s Exact test was used when
indicated.
Different logistic regression models were developed to test the adjusted RR of various risk
factors using modified logistic regression model [23]. All models considered the impairment
of glucose intolerance as a binary outcome and various covariates were adjusted for clinically
significant confounders as maternal age and BMI. Bootstrapping of the regression models was
performed with 1,000 samples and Bias Corrected and accelerated (BCa) 95% Confidence
Intervals (C.I.) were reported. P-value of less than 0.05 was considered as statistically
significant.
Ethical approval
The study was conducted after the approval of King Saud University review board with
approval letter number 15/0445/IRB. The study was conducted according to the principles
expressed in the Declaration of Helsinki.
Results
From a total of 3130 women, who delivered in KKUH and participated in RAHMA study, 712
women did not fulfil the inclusion criteria, 1067 women either declined to participate or had
left the city, 513 women could not be contacted because they changed their contact informa-
tion and 431 women were not yet one year postpartum when the study concluded leaving 407
women who fulfil the inclusion criteria and agreed to participate in the study (Fig 1).
Table 1 shows comparison of the main determinants of impaired glucose tolerance between
women who participated in the study and those who did not. There was no significant differ-
ence between the two groups except for the prevalence of GDM.
Table 2 compares the characteristics of the three groups. From 133 women with history of
GDM; 75 (56.4%) women developed either diabetes or prediabetes, while only 82 (30.1%)
from 272 women without history of GDM developed prediabetes and none from this group
Fig 1. Recruitment and analysis of the cohort.
https://doi.org/10.1371/journal.pone.0210024.g001
RAHMA; incidence of postpartum glucose intolerance
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developed diabetes (Table 2). There was no statistical difference between the three groups in
parity (Table 2). However, normoglycemic women were significantly younger, had signifi-
cantly lower mean BMI prior to the index pregnancy, compared to women with prediabetes
and diabetes; (27.4 ±5.6, 28.3 ±5.5, 34.3 ±5.5 respectively, P<0.01). Similarly, the current mean
BMI of normoglycemic women was significantly lower than that of the prediabetic and dia-
betic women (29.3 ± 6.2, 31.1 ± 6.6, 36.2 ± 4.8 respectively, P<0.01). Of the women who devel-
oped postpartum diabetes 14 (93.3%) had pre-pregnancy BMI of� 30 kg/m2, while the
corresponding proportion from the prediabetes group and the normoglycemic group was 66
(46.4%) and 108 (43.2%) respectively (Table 2). Measurements of WC and diastolic blood pres-
sure, for women with prediabetes and diabetes, were significantly higher than those of normo-
glycemic women (Table 2). Significantly more women with prediabetes and diabetes had
family history of diabetes, history of GDM in the index pregnancy, higher mean fating glucose
level and 2 hours post glucose load. In addition, they more frequently needed insulin for con-
trol of GDM during pregnancy, compared to normoglycemic women (Table 2).
However, in multivariable logistic regression analysis with bootstrapping, only history of
GDM, (BCa-RR 1.74, 95% C.I. (1.06 to 2.84), P = 0.01), obesity (BCa-RR 1.69, 95% C.I. (1.01–
3.11), P = 0.04) and diastolic blood pressure, (BCa-RR 1.04, 95% C.I. (1.01–1.09), P = 0.03)
remained as predictors of postpartum glucose intolerance (Table 3 and Fig 2).
Discussion
The incidence of prediabetes and diabetes, in this sub-group of RAHMA study, were 35% and
3.6% respectively. The results showed that women who developed glucose intolerance (diabe-
tes and prediabetes), were significantly more obese, during pregnancy and in the postpartum
period. Furthermore, a significantly higher proportion from this group had a history of GDM
and a family history of type 2 diabetes. They had higher diastolic blood pressure and higher
blood glucose levels during pregnancy and they needed insulin more frequently, for control of
GDM, than normoglycemic group. The main predictors of developing glucose intolerance in
this cohort were history of GDM, postpartum obesity and diastolic blood pressure.
This is, to our knowledge, the first study from Saudi Arabia to report on the incidence of
glucose intolerance in postpartum women, one year after delivery. In a national survey of the
general adult population in Saudi Arabia, the prevalence of prediabetes was estimated to be
25%, which is lower than the 35% rate found in this study. Moreover, the incidence (new
cases) of diabetes in this study is higher than the incidence of 1.3% estimated previously for the
same age group and gender by Al-Quwaidhi el al [24]. These differences in incidence and
Table 1. Comparison of characteristics of women who participated and those did not participate in the study.
Participants
N = 407
Non-participants
N = 1580
p-value
Age 30.4±5.8 29.9±5.9 0.13
parity 3.17±2.4 3.19±2.2 0.88
Pre-pregnancy BMI 27.6± 5.9 27.9±5.7 0.34
Term BMI 31.7±6.2 31.2±5.6 0.25
FBG 4.6±2.8 4.7±1.8 0.50
GDM 142 (34.9) 285 (18.0) <0.01
BMI, Body Mass Index; FBG, Fasting blood glucose; GDM, Gestational Diabetes
From the study participants; 250 (61.4%, BCa 95% C.I. = 57.2–66.1%) women were normoglycemic, 142 (35%, BCa 95% C.I. = 30.7–38.8%) women had prediabetes and
15 (3.6%, BCa 95% C.I. = 2.2–5.2%) women were diabetic.
https://doi.org/10.1371/journal.pone.0210024.t001
RAHMA; incidence of postpartum glucose intolerance
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Table 2. Comparison of characteristics of women with normal glucose tolerance, impaired glucose tolerance and diabetes.
Normal glucose tolerance (n = 250) Impaired glucose tolerance(n = 142) Diabetes (n = 15) p-value
Pre-pregnancy characteristics
Age (years) 31.6±5.5 32.6±6.2 35.6±5.8 0.02
95% BCa C.I. 30.2–31.8 31.1–33.6 31.2–37.5 0.04
parity
primiparous 67 (26.9) 35 (24.8) 2 (13.3) 0.49
multiparous 183 (73.1) 107 (75.2) 13 (86.7)
Family history of type 2 diabetes
Yes 172 (68.7) 112 (78.7) 13 (86.7) 0.04
Pre-pregnancy BMI 27.4 ±5.6 28.3 ±5.5 34.3 ±5.5 <0.01
95% BCa C.I. 26.3–28.1 27.2–29.4 30.8–37.8 <0.01
BMI < 25 84 (33.6) 43 (30.4) 0 (0.0) <0.01
BMI 25.1–29.9 58 (23.2) 33 (23.2) 1 (6.7)
BMI� 30 108 (43.2) 66 (46.4) 14 (93.3)
Pregnancy characteristics
Pregnancy glucose level
Fasting 4.6 ± 0.69 4.8 ±0.64 5.5 ±0.77 <0.01
95% BCa C.I. 4.6–4.8 4.7–4.9 5.1–6.1 <0.01
I hour 7.6 ±1.9 7.9 ±2.2 8.1 ±2.2 0.28
95% BCa C.I. 7.22–7.87 7.37–8.61 8.91–10.92 0.16
2 hours 6.3 ± 2.1 6.6 ± 2.1 7.6 ±2.2 0.04
95% BCa C.I. 5.90–6.58 6.08–7.18 8.60–9.01 0.03
GDM
Yes 58 (23.2) 60 (42.3) 15 (100.0) <0.01
Treatment of GDM
Diet 56 (96.6) 56 (93.3) 9 (60.0) <0.01
insulin 2 (3.4) 4 (6.7) 6 (40.0)
Post-pregnancy anthropometric measurements
Current BMI (kg/m2)
BMI (mean ±SD) 29.3 ± 6.2 31.1 ± 6.6 36.2 ± 4.8 0.01
95% BCa C.I. 28.0–29.9 29.7–32.2 33.9–39.7 <0.01
BMI< 25 69 (27.7) 26 (18.4) 0 (0.0) <0.01
BMI 25.1–29.9 75 (30.1) 37 (26.2) 2 (13.3)
BMI� 30 105 (42.2) 78 (55.3) 13 (86.7)
WC (mean ±SD) (cm) 82.4 ± 14.4 87.2 ± 13.0 89.2± 10.0 <0.01
95% BCa C.I. 76.26–79.85 79.76–85.67 87.22–94.07 <0.01
Breast feeding (at 4 months) 110 (44.0) 65 (45.7) 6 (40.0) 0.42
Hormonal contraceptive use 111 (44.4) 53 (37.1) 7(46.7) 0.34
Systolic Blood Pressure 112.9±13.5 113.4±17.5 115.2±14.6 0.80
95% BCa C.I. 110.61–114.99 108.53–116.92 112.85–121.90 0.83
Diastolic blood pressure 67.8±9.2 71.6±8.7 72.5±7.2 0.01
95% BCa C.I. 66.35–69.32 69.41–73.45 73.56–75.11 0.03
95% BCa C.I., 95% Bias Corrected and accelerated Confidence Interval; GDM, Gestational diabetes; BMI, Body Mass Index; WC, Waist circumference
All women who developed type 2 diabetes had history of GDM and none of the women who were normoglycemic during pregnancy developed type 2 diabetes. The RR
of all factors for development of glucose intolerance is shown in Table 3. History of GDM in the index pregnancy almost doubled the risk of developing postpartum
glucose intolerance; (RR 1.91, 95% confidence intervals (C.I.) (1.31 to 2.78), P<0.01). Similarly, women with BMI� 30 kg/m2, had almost double the risk of developing
postpartum glucose intolerance compared to women with lower BMI, (RR 1.79, 95% C.I. (1.17–2.97), P = 0.02) (Table 3). In addition higher diastolic blood pressure
increased the risk of developing diabetes and IGT (RR 1.03, 95% C.I. (1.001–1.066), P = 0.04).
https://doi.org/10.1371/journal.pone.0210024.t002
RAHMA; incidence of postpartum glucose intolerance
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prevalence may be due to difference in the distribution of the risk factors between the general
population and our cohort which included high proportion of women with GDM.
Recent reports from Italy on the prevalence of hyperglycaemia in women who had GDM
showed rates similar to those found in our study (32% and 4% for prediabetes and diabetes
respectively) [25]. However, reports from Iran showed lower rates than ours for prediabetes
and higher rates for diabetes (17.5% prediabetes and 4.5% type 2 diabetes) [26]. These differ-
ences in rates can be explained by the variation in the criteria for diagnosing glucose intoler-
ance, the duration of follow-up period, as both studies examined glycemic tolerance at 6–12
weeks rather than after one year as in our study, in addition to the ethnic differences between
the studied population [8].
Similar to previous reports, this study showed that the risk factors for the development of
impaired glucose tolerance were significantly more prevalent in women who developed diabe-
tes and prediabetes compared to those who remained normoglycemic [8,9]. These include fac-
tors existing before the index pregnancy such as pre-pregnancy weight and family history of
type 2 diabetes, factor which occurred during the index pregnancy such as the need to use
insulin to control blood glucose level and high FBG; in addition, to postpartum factors such as
obesity and blood pressure readings.
Nevertheless, when we controlled for confounders, our results showed that only GDM,
postpartum obesity and diastolic blood pressure remained as significant risk factors for the
development of glucose intolerance.
Table 3. Relative risk of developing glucose intolerance (prediabetes and type 2 diabetes) among the study cohort.
Risk Factor RR (95% C.I.) p- value BCa RR(95% C.I.) p-value
Age (years) 1.02(0.98–1.05) 0.41 1.01 (0.98–1.05) 0.43
parity
primiparous 1
multiparous 1.09 (0.69–1.69) 0.71 0.90 (0.55–1.49) 0.69
Family history of DM
no 1
yes 1.41 (0.90–2.20) 0.13 1.27(0.77–2.13) 0.31
Pre-pregnancy BMI
Less than 25 1
25.1–29.9 1.11 (0.63–1.94) 0.72 o.85(0.43–1.54) 0.59
30+ 1.28 (0.81–2.03) 0.29 0.95 (0.55–1.69) 0.87
Pregnancy fasting glucose level 1.30 (0.99–1.69) 0.05 1.21 (0.91–1.69) 0.18
GDM
No 1
yes 1.91 (1.31–2.78) <0.01 1.74 (1.06–2.84) 0.01
Treatment of GDM
Diet 1
insulin 1.37 (0.56–3.35) 0.48 1.49(0.53–3.85) 0.42
Current BMI (kg/m2)
Less than 25 1
25.1–29.9 1.31 (0.74–2.32) 0.34 1.22 (0.68–2.26) 0.49
� 30 1.79 (1.17–2.97) 0.02 1.69 (1.01–3.11) 0.04
Diastolic Blood Pressure 1.03 (1.001–1.066) 0.04 1.04 (1.01–1.09) 0.03
RR, Relative risk; BCa C.I., Bias Corrected and accelerated confidence interval; C.I., Confidence intervals; DM,
Diabetes mellitus; GDM, Gestational Diabetes.
https://doi.org/10.1371/journal.pone.0210024.t003
RAHMA; incidence of postpartum glucose intolerance
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Long term follow-up of women with GDM showed a seven to ten-fold increase in risk of
developing type 2 diabetes compared to women who were not diagnosed with GDM [6,27].
The results from a recently published study from Korea showed that history of GDM, as the
sole risk factor, increased the risk of developing diabetes by 2.5-fold [28]. Moreover, women
with the combination of history of GDM and obesity had the highest cumulative incidence of
type 2 diabetes compared to women with combination of any other risk factors [28].
There is great variation in the global prevalence of GDM [29]. Recent reports from Saudi
Arabia estimated that more than 25% of pregnant Saudi women develop GDM based on
World Health Organization diagnostic criteria [17,20]. Such high rate of GDM will continue
to contribute to the epidemic of diabetes and its complications in the country [30] unless a
robust screening program and appropriate interventions are established for this at-risk popula-
tion [14,15].
Obesity was another predictor of progression to prediabetes and diabetes in this study. Sim-
ilar results were reported by previously published studies [31,32]. Obesity imposes risk equal
to that of GDM for developing hyperglycemia in postpartum women [28]. In addition, women
with GDM who are obese, have 1.5-fold increase in the risk of developing diabetes in postpar-
tum period compared to those who have normal BMI [32]. Recent reports from Saudi Arabia
showed that more than 68% of women in the reproductive age group are either overweight or
obese [19], and that the prevalence of GDM and Pre-GDM increases with the increase in BMI
[17].
Another risk factor for persistent hyperglycemia in the postpartum period is diastolic blood
pressure. Although blood pressure levels for all groups in this study were blew those of hyper-
tension [33], but higher diabolic blood pressure was a predictor of development of hyperglyce-
mia. Similar results were reported by Vambergue et al who speculated that most of the women
who develop hyperglycemia following GDM will develop hypertension later in life [34]
Based on a recently published systematic review, lifestyle interventions, including healthy
eating and physical activity, are effective for the treatment of women with GDM [35]. Women
who received lifestyle interventions were more likely to achieve the target weight in the postna-
tal period and their neonates were less likely to be large for gestational age [35]. Furthermore,
Fig 2. Forest plot of bias corrected relative risk for developing glucose intolerance.
https://doi.org/10.1371/journal.pone.0210024.g002
RAHMA; incidence of postpartum glucose intolerance
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lifestyle interventions following delivery were effective in the prevention of progression to type
2 diabetes [36].
Strength and limitations of the study
This study is the first to quantify the problem of glucose intolerance following GDM in a Saudi
population. It provides valuable information for policy makers and researchers about the risk
factors for progression to type 2 diabetes in Saudi women. However, the study population may
not be representative of the whole population especially that there were significantly more
women with GDM in the study group compared to the women who did not participate in the
study (Table 1). This may be due to the fact that women who had pregnancies complicated
with GDM were concerned about their health and were more willing to participate in the
study than those who had normal pregnancy. Another limitation of this study is the relatively
small number of participants compared to the total number of women who participated in
RAHM from KKUH. This is due to the poor return of participants from the first cohort. Poor
postpartum response to recall for follow-up is faced by other researchers in the Middle East
[37]. Many factors contribute to this phenomenon including inadequate referral system, lack
of national health information system, and lack of national registries in addition to the lack of
the culture of longitudinal research in many of the Middle Eastern communities.
Implication to practice
• Establishing a national program for screening adults, especially for women with history of
GDM, for diabetes and prediabetes is a prudent step towards controlling the epidemic of dia-
betes in the country. Such programs were proven to be cost-effective given the saving in
averting the cost of morbidity and premature death from complications of diabetes [38].
• Implementation of evidence based strategy for the treatment of GDM that includes lifestyle
modification is an essential step in the control of postpartum progression to type 2 diabetes
• It is important to increase the awareness of Saudi women in the reproductive age group
about the risks related to obesity and GDM and the importance of postnatal screening
Implication to research
Research should be directed towards effective interventions to reduce the burden of obesity in
Saudi pregnant and postpartum women.
Conclusion
The incidence of postpartum glucose intolerance (diabetes and prediabetes) is very high in
Saudi women. Both GDM and obesity are strong predictors of glucose intolerance.
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